Sliding Scale Insulin Should NOT Be Used—Transition to Scheduled Basal Insulin Instead
Do not use sliding scale insulin (SSI) as the sole insulin regimen for this patient in the skilled nursing facility. The American Diabetes Association explicitly discourages SSI use in long-term care settings 1. Instead, you should transition to a scheduled basal insulin regimen with or without fixed-dose mealtime insulin.
Why Sliding Scale Insulin Fails
SSI is ineffective and potentially harmful in SNF settings because:
- It treats hyperglycemia reactively rather than preventing it
- It's associated with 3-fold higher risk of hyperglycemic episodes when used alone 2
- Only 12% of SSI injections actually achieve target glucose control 3
- 84% of SSI doses result in persistent hyperglycemia despite treatment 3
- It increases nursing workload without improving outcomes 4
The Correct Approach: Transition to Scheduled Insulin
Here's the specific algorithm to follow 1:
Step 1: Calculate Insulin Requirements
- Review the patient's average daily insulin requirement over the prior 5-7 days (if they were on any insulin previously)
- If starting fresh, estimate based on weight (typically 0.2-0.3 units/kg for type 2 diabetes)
Step 2: Initiate Basal Insulin
- Give 50-75% of the average daily insulin requirement as basal insulin (e.g., glargine, detemir, or NPH)
- Consider giving basal insulin in the morning rather than bedtime to impact postprandial hyperglycemia and reduce early-morning hypoglycemia risk 1
- Stop any SSI that was being used as the sole regimen
Step 3: Address Postprandial Hyperglycemia
If glucose remains elevated after meals:
- Add fixed-dose mealtime insulin (not sliding scale) with meals
- Alternatively, restart or add non-insulin agents if appropriate (metformin, etc.)
Step 4: Use Correction Doses Appropriately (If Needed)
If correction insulin is truly needed:
- Use it in addition to scheduled basal and mealtime insulin, not as the primary regimen
- If correction doses are required frequently before the same meal, add the average correction dose to the scheduled insulin at the preceding meal 1
- Example: If consistently needing 2-3 units correction before lunch, increase the scheduled breakfast insulin by 2 units
Special Considerations for SNF Patients
For Patients with Irregular Dietary Intake or Cognitive Decline
- Use scheduled basal insulin as the foundation
- Keep the regimen simple with goal of avoiding hypoglycemia as the priority 1
- May use a very simple scale like: "Give 4 units of mealtime insulin if glucose >300 mg/dL" 1
- Ensure adequate hydration, especially when glucose >300 mg/dL
Short-Term SSI Use (Only Acceptable Scenario)
SSI may be used temporarily only during:
- Acute illness with unpredictable intake
- First few days of admission while stabilizing
As soon as the patient stabilizes, return to scheduled insulin regimen 1.
Regarding the Held Mounjaro
Since tirzepatide (Mounjaro) is a GLP-1/GIP receptor agonist that was likely providing significant glucose control, holding it will unmask the patient's underlying insulin deficiency. The half-life is approximately 5 days 5, so glucose will rise progressively over the first week off medication. This makes scheduled basal insulin even more critical—SSI will consistently fail to prevent hyperglycemia in this scenario.
Common Pitfalls to Avoid
- Don't continue SSI beyond the first week of SNF admission—this is explicitly discouraged by guidelines 1, 6
- Don't use SSI alone without basal insulin—this triples hyperglycemia risk 2
- Don't forget to adjust the scheduled insulin doses based on patterns, rather than repeatedly giving correction doses 1
- Don't aim for overly strict control in frail SNF patients—target glucose 140-180 mg/dL preprandial to minimize hypoglycemia risk 6
The evidence is clear and consistent: scheduled basal insulin with or without fixed mealtime doses is superior to sliding scale insulin in every measurable outcome 1, 4, 7, 3, 2.